Download presentation
Presentation is loading. Please wait.
Published byBrittney Arnold Modified over 5 years ago
1
Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins E.J. Giamarellos-Bourboulis, N. Tziolos, C. Routsi, C. Katsenos, I. Tsangaris, I. Pneumatikos, G. Vlachogiannis, V. Theodorou, A. Prekates, E. Antypa, V. Koulouras, N. Kapravelos, C. Gogos, E. Antoniadou, K. Mandragos, A. Armaganidis Clinical Microbiology and Infection Volume 22, Issue 6, Pages (June 2016) DOI: /j.cmi Copyright © 2016 The Authors Terms and Conditions
2
Fig. 1 Case–control matching process. Abbreviations: CCI, Charlson's Co-morbidity Index; IgGAM, IgM-enriched polyclonal immunoglobulin preparation; MDR, multidrug-resistant. Clinical Microbiology and Infection , DOI: ( /j.cmi ) Copyright © 2016 The Authors Terms and Conditions
3
Fig. 2 Survival plots for the patients treated with an IgM-enriched polyclonal immunoglobulin preparation (IgGAM) and the comparator group until day 28; statistical comparison between the two groups is shown. Clinical Microbiology and Infection , DOI: ( /j.cmi ) Copyright © 2016 The Authors Terms and Conditions
4
Fig. 3 Time to breakthrough bacteraemia for cases treated with an IgM-enriched polyclonal immunoglobulin preparation (IgGAM) and matched comparators; statistical comparison between the two groups is shown. Clinical Microbiology and Infection , DOI: ( /j.cmi ) Copyright © 2016 The Authors Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.